Skip to content

Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim.

Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04329936
Enrollment
30
Registered
2020-04-01
Start date
2020-05-31
Completion date
2021-05-31
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health of Migrant Population

Keywords

Mental health, Psychiatric diseases, Migration, Retention center

Brief summary

In 2019, the lack of studies about mental health of the detained population at retention centers in France is pointed out by the report of Controller-General for Places of Deprivation of Liberty. The aim of this study is to contribute to this relatively untouched field by describing which psychiatric pathologies are encountered in this population who went through migration and retention. Having a clearer picture of the situation can help to provide a more adapted psychiatric care in retention centers. The results are expected to show a higher rate of psychiatric disease than in the general population including addiction to substance, anxiety disorder and post-traumatic stress disorder (PTSD).

Interventions

BEHAVIORALRetention center Geispolsheim population

All recently held individuals in the retention center can be included in the study after signing the information and consent protocol.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any male person in the first week of detention at CRA Geispolsheim who gave their non-opposition to participation in the study. * Information and consent protocol signed

Exclusion criteria

* Refuse to participate to the study

Design outcomes

Primary

MeasureTime frameDescription
Mini International Neuropsychiatric Interview validated and translated in the language used by the interviewed person.1 hourThe interview is led by the investigator in the presence of a translator if necessary.

Countries

France

Contacts

Primary ContactRADJI Djamel
djamel.radji@chru-strasbourg.fr+33 3 88 11 65 42

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026